{"id":2527,"date":"2007-05-04T00:11:06","date_gmt":"2007-05-03T23:11:06","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=2527"},"modified":"2013-09-20T17:09:43","modified_gmt":"2013-09-20T17:09:43","slug":"access-to-abbott-drugs-in-thailand","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/2527","title":{"rendered":"Access to Abbott drugs in Thailand"},"content":{"rendered":"<p><strong>The issue of drug pricing and access to the new formulation of lopinavir\/r (Kaletra) in Thailand continues to run (see the last two issues of HTB).<\/strong><\/p>\n<p>The links below are to recent coverage of this issue on kaisernetwork.org<\/p>\n<p>Thailand will stand by decision to issue compulsory licenses, Health Minister says (3 May)<br \/>\n<a href=\"http:\/\/www.kaisernetwork.org\/daily_reports\/rep_index.cfm?DR_ID=44628\">http:\/\/www.kaisernetwork.org\/daily_reports\/rep_index.cfm?DR_ID=44628<\/a><\/p>\n<p>U.S. trade representative places Thailand on priority watch list in annual report (1 May)<br \/>\n<a href=\"http:\/\/www.kaisernetwork.org\/daily_reports\/rep_index.cfm?DR_ID=44603\">http:\/\/www.kaisernetwork.org\/daily_reports\/rep_index.cfm?DR_ID=44603<\/a><\/p>\n<p>U.S. Ambassador to Thailand urges government to negotiate on drug pricing, compulsory licensing with U.S. drug companies (25 April) <a href=\"http:\/\/www.kaisernetwork.org\/daily_reports\/rep_index.cfm?DR_ID=44477\"><br \/>\nhttp:\/\/www.kaisernetwork.org\/daily_reports\/rep_index.cfm?DR_ID=44477<\/a><\/p>\n<p>Abbott offers to sell Aluvia in Thailand at discounted price (23 April)<br \/>\n<a href=\"http:\/\/www.kaisernetwork.org\/daily_reports\/rep_index.cfm?DR_ID=44409\">http:\/\/www.kaisernetwork.org\/daily_reports\/rep_index.cfm?DR_ID=44409<\/a><\/p>\n<p>Thailand will maintain compulsory licenses for Kaletra, efavirenz, despite price reductions, Health Minister says (16 April)<br \/>\n<a href=\"http:\/\/www.kaisernetwork.org\/daily_reports\/rep_index.cfm?DR_ID=44254\">http:\/\/www.kaisernetwork.org\/daily_reports\/rep_index.cfm?DR_ID=44254<\/a><\/p>\n<p>Abbott refuses invitation for second round of talks with Thai government over compulsory licensing of antiretroviral Kaletra (10 April) <a href=\"http:\/\/www.kaisernetwork.org\/daily_reports\/rep_index.cfm?DR_ID=44129\"><br \/>\nhttp:\/\/www.kaisernetwork.org\/daily_reports\/rep_index.cfm?DR_ID=44129<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The issue of drug pricing and access to the new formulation of lopinavir\/r (Kaletra) in Thailand continues to run (see the last two issues of HTB). The links below are to recent coverage of this issue on kaisernetwork.org Thailand will &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[38],"tags":[],"class_list":["post-2527","post","type-post","status-publish","format-standard","hentry","category-treatment-access"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/2527","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=2527"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/2527\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=2527"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=2527"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=2527"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}